Income Taxes (Tables)

12 Months Ended

Jan. 31, 2024

Income Tax Disclosure [Abstract]

Schedule of Income before Income Tax, Domestic and Foreign

The components of net loss before income taxes were as follows:

	Year Ended January 31,
	2024		2023		2022
	(in thousands)
Domestic	$	(457,788)	$	(342,999)	$	(131,916)
Foreign	158		(4,276)		(3,255)
Net loss before income taxes	$	(457,630)	$	(347,275)	$	(135,171)

Schedule of Components of Income Tax Expense (Benefit)

The components of the provision for (benefit from) income taxes were as follows:

	Year Ended January 31,
	2024		2023		2022
	(in thousands)
Current
Federal	$	218	$	—	$	—
State	17		44		17
Foreign	1,942		1,345		359
Total current	$	2,177	$	1,389	$	376
Deferred
Federal	$	—	$	1	$	(1,242)
State	—		—		(423)
Foreign	(2,198)		(3,557)		(1,641)
Total deferred	(2,198)		(3,556)		(3,306)
Total benefit from income taxes	$	(21)	$	(2,167)	$	(2,930)

Schedule of Effective Income Tax Rate Reconciliation

A reconciliation of the U.S. federal statutory rate to the Company’s effective tax rate was as follows:

	Year Ended January 31,
	2024		2023		2022
Tax at federal statutory rate	21.0	%	21.0	%	21.0	%
State tax rate, net	—	%	—	%	—	%
Warrant and earnout revaluation	—	%	—	%	20.9	%
Stock-based compensation	(2.6	%)	—	%	8.0	%
Intangible assets amortization	—	%	—	%	1.3	%
Change in valuation allowance	(19.5	%)	(18.9	%)	(45.5	%)
Transaction cost	—	%	—	%	(1.2	%)
Research and development tax credits	0.6	%	0.8	%	2.8	%
Section 162(m) executive compensation limitation	—	%	(1.2)	%	(5.3)	%
Other	0.6	%	(1.1)	%	0.2	%
Effective tax rate	0.1	%	0.6	%	2.2	%

Schedule of Deferred Tax Assets and Liabilities

The significant components of the Company’s deferred tax assets and liabilities as of January 31, 2024 and 2023 were as follows:

	Year Ended January 31,
	2024		2023
	(in thousands)
Deferred tax assets:
Net operating losses	$	246,396	$	216,642
Research & development credits	42,541		34,406
Deferred revenue	27,788		18,124
Accruals and reserves	47,279		18,837
Stock-based compensation	15,300		11,706
Operating lease liabilities	5,524		6,589
Capitalized research & development expense	69,070		39,761
Total deferred tax assets	453,898		346,065
Less: valuation allowance	(439,447)		(328,786)
Deferred tax liabilities:
Depreciation and amortization	(557)		(390)
Operating lease right-of-use assets	(3,886)		(5,723)
Acquired intangible assets	(18,985)		(22,058)
Deferred commission	(2,275)		(2,095)
Total deferred tax liabilities	(25,703)		(30,266)
Net deferred tax assets (liabilities)	$	(11,252)	$	(12,987)

Schedule of Unrecognized Tax Benefits Roll Forward

The following table summarizes the activity related to unrecognized tax benefits as follows:

	Year Ended January 31,
	2024		2023		2022
	(in thousands)
Unrecognized tax benefits - beginning	$	25,762	$	19,238	$	9,402
Gross changes - prior period tax position	—		109		2,039
Gross changes - current period tax position	6,331		6,415		7,797
Unrecognized tax benefits — ending	$	32,093	$	25,762	$	19,238